Faculty

Moira Rynn

Consulting Professor in the Department of Psychiatry and Behavioral Sciences

Psychiatry, Child & Family Mental Health & Developmental Neuroscience
School of Medicine

Chair of Psychiatry and Behavioral Sciences

Psychiatry & Behavioral Sciences
School of Medicine
Show all faculty appointments and affiliations

Dr. Rynn is Chair for the Department of Psychiatry and Behavioral Sciences at Duke University School of Medicine. She is an internationally-renowned expert in the treatment of pediatric mood and anxiety disorders. She has spent her career focused on improving treatments for children, adolescents, and young adults with treatment refractory mood and anxiety disorders. Her most recent studies have examined novel augmentation treatment strategies for pediatric Obsessive-Compulsive Disorder and treatment models for adolescent depression in the primary care setting.  Dr. Rynn received her medical degree from Rutgers University. She completed her internship and residency in psychiatry at the University of Pennsylvania Perelman School of Medicine and served as Chief Resident.  After completing her adult psychiatry training, she completed a Child and Adolescent Psychiatry Fellowship at the Children’s Hospital of Philadelphia followed by a Neuropsychopharmacology Research Fellowship sponsored by the NIMH at the University of Pennsylvania Perelman School of Medicine. Prior to joining Columbia University, Dr. Rynn was medical director of the Mood and Anxiety Disorders Section of the Department of Psychiatry at the University of Pennsylvania Perelman School of Medicine.


Education & Training

M.D. 1991

Rutgers New Jersey Medical School

Intern in Psychiatry, Psychiatry

University of Pennsylvania School of Medicine

Resident, Adult Psychiatry, Psychiatry

University of Pennsylvania School of Medicine

Chief Resident, Psychiatry, Psychiatry

University of Pennsylvania School of Medicine

Resident, Division of Child and Adolescent Psychiatry, Psychiatry

Children's Hospital of Philadelphia

Postdoctoral Research Fellow, Psychiatry

National Institutes of Health

Publications

The Effects of Youth Anxiety Treatment on School Impairment: Differential Outcomes Across CBT, Sertraline, and their Combination.

PMID 31087216
Read Full Text

Primary Care: Meeting the Mental Health Care Needs of Adolescents With Depression.

PMID 30926071
Read Full Text

Secondary Outcomes From the Child/Adolescent Anxiety Multimodal Study: Implications for Clinical Practice.

PMID 30906874
Read Full Text

Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.

PMID 28384010
Read Full Text

Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.

PMID 28165762
Read Full Text

Child/adolescent anxiety multimodal study: Evaluating safety

Read Full Text

Child/Adolescent anxiety multimodal study: evaluating safety.

PMID 25721183
Read Full Text

Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.

PMID 25449861
Read Full Text

Web-based interventions for youth internalizing problems: a systematic review.

PMID 25457924
Read Full Text

Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.

PMID 24417601
Read Full Text

Therapist Factors and Outcomes in CBT for Anxiety in Youth.

PMID 25419042
Read Full Text

Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR.

PMID 24061331
Read Full Text

SMARTer discontinuation trial designs for developing an adaptive treatment strategy.

PMID 23083023
Read Full Text

Psychopharmacologic treatment of children and adolescents with anxiety disorders.

PMID 22800992
Read Full Text

Childhood anxiety: lessons learned.

PMID 22801002
Read Full Text

Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder.

PMID 22511364
Read Full Text

Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders

Read Full Text

Dr Barber and colleagues reply

Read Full Text

Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

PMID 22152401
Read Full Text

Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.

PMID 22122292
Read Full Text

Screening parents during child evaluations: exploring parent and child psychopathology in the same clinic.

PMID 21515193
Read Full Text

Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.

PMID 21135327
Read Full Text

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

PMID 20051130
Read Full Text

Childhood anxiety disorders: Best treatment options and practice

Read Full Text

Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

PMID 18974308
Read Full Text

Influence of gender on the clinical presentation of generalized anxiety disorder, and response to treatment with Pregabalin

Read Full Text

The varied manifestations of anxiety disorder

Read Full Text

Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.

PMID 17267793
Read Full Text

Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: Two placebo-controlled trials

Read Full Text

Social anxiety disorder in children and adolescents: epidemiology, diagnosis, and treatment.

PMID 17705562
Read Full Text

Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.

PMID 17017821
Read Full Text

The psychometric properties of the MASC in a pediatric psychiatric sample.

PMID 16464701
Read Full Text

Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.

PMID 16160630
Read Full Text

Generalized anxiety disorder: acute and chronic treatment.

PMID 15448583
Read Full Text

Paroxetine in the treatment of generalised anxiety disorder.

PMID 15264994
Read Full Text

49th Annual Meeting of the American Academy of Child & Adolescent Psychiatry. 22-27 October 2002, San Francisco, CA, USA.

PMID 12667122
Read Full Text

Ziprasidone-associated mania: a case series and review of the mechanism.

PMID 12656943
Read Full Text

Efficacy and safety of nefazadone in the treatment of adolescents with major depressive disorder

Read Full Text

Desipramine toxicity with terbinafine.

PMID 11870022
Read Full Text

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.

PMID 11729017
Read Full Text

What is generalized anxiety disorder?

PMID 11414550
Read Full Text

Assessment of Psychiatric Comorbidity in Children Infected with Human Immunodeficiency Virus, Type 1

Read Full Text

Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.

PMID 29099547
Read Full Text
Show More